These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20206372)

  • 1. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection.
    Hühn MH; McCartney SA; Lind K; Svedin E; Colonna M; Flodström-Tullberg M
    Virology; 2010 May; 401(1):42-8. PubMed ID: 20206372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
    Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
    Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production.
    Valaperti A; Nishii M; Liu Y; Naito K; Chan M; Zhang L; Skurk C; Schultheiss HP; Wells GA; Eriksson U; Liu PP
    Circulation; 2013 Oct; 128(14):1542-54. PubMed ID: 24030499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication.
    Wessely R; Klingel K; Knowlton KU; Kandolf R
    Circulation; 2001 Feb; 103(5):756-61. PubMed ID: 11156890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
    J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role for interferon-beta in coxsackievirus B3 infection.
    Deonarain R; Cerullo D; Fuse K; Liu PP; Fish EN
    Circulation; 2004 Dec; 110(23):3540-3. PubMed ID: 15249500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.
    Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U
    PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
    Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC
    PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus.
    Wang JP; Cerny A; Asher DR; Kurt-Jones EA; Bronson RT; Finberg RW
    J Virol; 2010 Jan; 84(1):254-60. PubMed ID: 19846534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
    Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
    Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
    J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4.
    Frisancho-Kiss S; Nyland JF; Davis SE; Frisancho JA; Barrett MA; Rose NR; Fairweather D
    Brain Res; 2006 Dec; 1126(1):139-47. PubMed ID: 16949558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells.
    Li M; Wang X; Yu Y; Yu Y; Xie Y; Zou Y; Ge J; Peng T; Chen R
    Virus Res; 2014 Jan; 179():177-86. PubMed ID: 24177271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection.
    Flodström M; Horwitz MS; Maday A; Balakrishna D; Rodriguez E; Sarvetnick N
    Virology; 2001 Mar; 281(2):205-15. PubMed ID: 11277693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.